Equities Analysts Set Expectations for PAHC Q2 Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Equities research analysts at Zacks Research upped their Q2 2026 earnings per share estimates for shares of Phibro Animal Health in a research report issued to clients and investors on Tuesday, January 7th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $0.49 per share for the quarter, up from their previous forecast of $0.47. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q3 2026 earnings at $0.36 EPS, Q4 2026 earnings at $0.50 EPS, FY2026 earnings at $1.66 EPS and FY2027 earnings at $2.12 EPS.

A number of other brokerages also recently commented on PAHC. StockNews.com raised Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 4th. Barclays boosted their target price on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. Finally, Morgan Stanley boosted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $20.50.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $21.48 on Thursday. Phibro Animal Health has a 1-year low of $10.03 and a 1-year high of $25.98. The company has a market cap of $870.00 million, a P/E ratio of 49.95, a P/E/G ratio of 0.58 and a beta of 0.53. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The stock has a 50-day moving average of $22.85 and a two-hundred day moving average of $21.06.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.23%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 111.63%.

Institutional Investors Weigh In On Phibro Animal Health

Several large investors have recently modified their holdings of the stock. Brandes Investment Partners LP raised its stake in shares of Phibro Animal Health by 1.2% during the second quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock worth $40,521,000 after purchasing an additional 29,071 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Phibro Animal Health by 5.7% during the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock worth $13,005,000 after acquiring an additional 42,086 shares during the period. Dana Investment Advisors Inc. grew its holdings in Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after acquiring an additional 75,546 shares during the period. Geode Capital Management LLC grew its holdings in Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after acquiring an additional 27,201 shares during the period. Finally, American Century Companies Inc. grew its holdings in Phibro Animal Health by 119.6% during the second quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock worth $5,822,000 after acquiring an additional 189,068 shares during the period. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.